The Role of αA-Crystallin in Experimental Autoimmune Uveitis

Author(s): L. Wang, L. Zhang, Z.-F. Wang, Z.-X. Huang, X. Hu, L. Gong, X. Tang, F. Liu, Z. Luo, W. Ji, W.-F. Hu, Z. Woodward, J. Zhu, Y.-Z. Liu, Q.D. Nguyen, D.W.-C. Li.

Journal Name: Current Molecular Medicine

Volume 15 , Issue 6 , 2015

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer


Uveitis refers to a group of ocular inflammatory diseases that can lead to blindness. For years, researchers have been trying to decipher the underlying mechanisms and develop therapeutic strategies using the model of experimental autoimmune uveitis (EAU). Recently, αA-crystallin has been found to be upregulated in EAU and can even ameliorate its severity through different mechanisms, suggesting its use as a potent therapeutic factor against uveitis. Here we review the protective role of αA-crystallin and discuss its functional mechanisms in EAU.

Keywords: αA-crystallin, experimental autoimmune uveitis, gene therapy, uveitis.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Page: [558 - 564]
Pages: 7
DOI: 10.2174/1566524015666150731101146
Price: $65

Article Metrics

PDF: 20